Silvant Capital Management LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Silvant Capital Management LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$11,181
-17.1%
2940.0%0.00%0.0%
Q2 2023$13,480
+12.2%
2940.0%0.00%0.0%
Q1 2023$12,010
-20.3%
2940.0%0.00%0.0%
Q4 2022$15,070
-5.8%
2940.0%0.00%0.0%
Q3 2022$16,000
-15.8%
2940.0%0.00%
-80.0%
Q2 2022$19,000
-17.4%
2940.0%0.01%
+25.0%
Q1 2022$23,000
-8.0%
2940.0%0.00%0.0%
Q4 2021$25,000
+4.2%
2940.0%0.00%0.0%
Q3 2021$24,0000.0%2940.0%0.00%0.0%
Q2 2021$24,000
-4.0%
2940.0%0.00%0.0%
Q1 2021$25,000
+4.2%
2940.0%0.00%0.0%
Q4 2020$24,0000.0%2940.0%0.00%0.0%
Q3 2020$24,000
-4.0%
2940.0%0.00%0.0%
Q2 2020$25,000
+4.2%
2940.0%0.00%
-20.0%
Q1 2020$24,000
-4.0%
2940.0%0.01%0.0%
Q4 2019$25,000
-3.8%
2940.0%0.01%0.0%
Q3 2019$26,000
-10.3%
294
-17.9%
0.01%0.0%
Q2 2019$29,0000.0%3580.0%0.01%0.0%
Q1 2019$29,000
+20.8%
3580.0%0.01%0.0%
Q4 2018$24,000
-14.3%
3580.0%0.01%
+66.7%
Q3 2018$28,000
+3.7%
3580.0%0.00%0.0%
Q2 2018$27,000
+17.4%
3580.0%0.00%0.0%
Q1 2018$23,0003580.00%
Other shareholders
BAXTER INTL INC shareholders Q2 2021
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders